EP3423061
COMBINATION THERAPY WITH SORAFENIB OR REGORAFENIB AND A PHOSPHORAMIDATE PRODRUG OF TROXACITABINE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.2.2017EP published:
7.8.2024EP application number:
17760400.6
EPO information:
European Patent Register
Max expiry date:
27.2.2037
Title in English:
COMBINATION THERAPY WITH SORAFENIB OR REGORAFENIB AND A PHOSPHORAMIDATE PRODRUG OF TROXACITABINELanguage of the patent:
English
Timeline
Today
28.2.2017EP application
7.8.2024EP Publication
Owner
Name:
Medivir AktiebolagAddress:
P.O. Box 1086, 141 22 Huddinge, SE
Inventor
Name:
ALBERTELLA, MarkAddress:
141 22 Huddinge, SE
Name:
ENEROTH, AndersAddress:
141 22 Huddinge, SE
Name:
KLASSON, BjörnAddress:
141 22 Huddinge, SE
Name:
ÖBERG, FredrikAddress:
141 22 Huddinge, SE
Name:
ÖHD, JohnAddress:
141 22 Huddinge, SE
Priority
Number:
1650274Date:
2.3.2016Country:
SE
Number:
1651204Date:
8.9.2016Country:
SE
Classification
Categories:
A61K 31/513, A61K 31/4412, A61K 31/675, A61K 31/685, A61P 35/00, A61K 31/44